FDA is investigating risk of severe hypocalcemia in dialysis patients taking Prolia (denosumab). After an interim safety
Tweet Content
FDA is investigating risk of severe hypocalcemia in dialysis patients taking Prolia (denosumab). After an interim safety data review reports of hypocalcemia w/ advanced CKD. Monitor Ca, use Ca & vit D supplements. Await further FDA information https://t.co/QMOtYs0eBY https://t.co/wzhIg53kCs
Links
COVID Highlights Dr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at #
Tweet Content
COVID Highlights
Dr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at #ACR22
https://t.co/DEUykGt8pT https://t.co/sz8GRRGrPH
Links
Do oral JAKs in atopic dermatitis cause VTE? Meta-analysis (15 RCTs, 466â¯993 pts) does NOT show increased risk of VTE
Tweet Content
Do oral JAKs in atopic dermatitis cause VTE? Meta-analysis (15 RCTs, 466 993 pts) does NOT show increased risk of VTE associated with AD & JAK inhibitors (HR 0.95) w/ low VTE incidence (0.05%) w/ JAKi and (0.03%) placebo. https://t.co/mO2DHzjVJw https://t.co/aaC82UStob
Links
Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta ( @bella_mehta) talks with Dr. Candace Feldman abou
Tweet Content
Photovoice: A New Visual Research Method in Lupus
Dr. Bella Mehta ( @bella_mehta) talks with Dr. Candace Feldman about Abstract 1099: Empowering Patients with Lupus Through Their Photographs at #ACR22.
https://t.co/tPizbi16Om https://t.co/lYUXaGEerA
Links
RT @DrCassySims: Is toci an option in refractory PMR? #ACR22 ðdouble-blind RCT ðª101 pts w/GC-resistant PMR (mod.
Tweet Content
Is toci an option in refractory PMR? #ACR22
📍double-blind RCT
💪101 pts w/GC-resistant PMR (mod. dz on pred. < 10 mg)
💉toci 8 mg/kg q4w + pred taper vs. placebo + pred taper over 24w
🌟49% in toci group stopped pred at week 24 vs. 20% in placebo
🌟AE similar b/t groups
RT @ACR_Journals: Just accepted in Arthritis & Rheumatology: Incidence, Prevalence, and Mortality of Lupus Nephriti
Tweet Content
Just accepted in Arthritis & Rheumatology:
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades—The Lupus Midwest Network (LUMEN)
https://t.co/StigaFb3YZ
Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims ( @DrCassySims) discusses abstract 0950 at #ACR22.
Tweet Content
Impact of COVID 19 on Pregnancies in Women with RMD
Dr. Cassy Sims ( @DrCassySims) discusses abstract 0950 at #ACR22.
https://t.co/qbFRV5P3eP https://t.co/cmS4n15L5e
Links
What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Dr Chao ( @doctorRBC) discusses Abstract 1510 at #ACR22
Tweet Content
What lifestyle factors affect TNF inhibitor efficacy in AxSpA?
Dr Chao ( @doctorRBC) discusses Abstract 1510 at #ACR22 . Abstract 1510: Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of TNF Inhibitors in AxSpA
https://t.co/h8ZniRF5rO https://t.co/SZq5bvYPzt
Links
RA-ILD: an update Dr. Julian Segan ( @JulianSegan) discusses Abstract #1393 and Abstract #0245 presented at #ACR22.
Tweet Content
RA-ILD: an update
Dr. Julian Segan ( @JulianSegan) discusses Abstract #1393 and Abstract #0245 presented at #ACR22.
https://t.co/5Vk4NaWzqc https://t.co/doqhqeNgdX
Links
